The Effectiveness of Probiotics in Neonatal Jaundice

Trial statusNot yet recruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age1-30
SponsorTanta University

About this trial

Hyperbilirubinemia is a prevalent problem in babies that necessitates medical attention. Probiotic administration as adjuvant therapy may have a positive impact on the pathological neonatal unconjugated hyperbilirubinemia.

Eligibility criteria

Qualifiers

Neonate suffered from pathological unconjugated hyper-bilirubinemia with Total serum bilirubin (TSB) between 5-15mg/dl and need phototherapy.

Disqualifiers

neonates who have kernicterus.

neonates who have ventilation problem.

neonates who have heart failure.

-neonates who have asphyxia.

Trial design

Treatments tested in this trial

  • Probiotic Formula

Treatment groups

44 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators